Human IL-4R binding antibody, antigen binding fragment thereof, and medical use thereof
US12162944B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 23, 2019 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | May 30, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a human IL-4R binding antibody, an antigen binding fragment thereof, and a medical use thereof. Provided are a chimeric antibody and a humanized antibody, including a CDR region from a human IL-4R binding antibody and an antigen binding fragment thereof, a pharmaceutical composition including the human IL-4R binding antibody and the antigen binding fragment thereof, and a use thereof as a drug treating allergic disease. Also provided is a use of the humanized antibody IL-4R binding antibody in preparing a drug used for treating IL-4R mediated diseases or illnesses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.